WATCH: How Covid-19 weighed on Life Healthcare

Life Healthcare CEO Peter Wharton-Hood talks to Business Day TV about the company’s interim results

Discovery and Mediclinic scale back plans for vaccine sites amid supply concerns

The companies put brakes on new sites as only 1.3-million Pfizer doses delivered

Life Healthcare says diversification has paid off

Profit falls almost double digits but hospital operator says it better adapted to handling the costs of Covid-19

Market welcomes Mediclinic’s exit from the UK

Spire Healthcare was hit hard ahead of Brexit as the National Health Service tried to contain costs

Pickup in patient activity encourages Mediclinic, even as third wave looms

The hospital group expects profits to improve amid signs that non-Covid-19 patient activity is gaining momentum

WATCH: How Netcare has recovered as it adapts to Covid-19

Netcare CEO Richard Friedland talks to Business Day TV about the effect the pandemic is having on the private hospital group’s balance sheet

WATCH: Dis-Chem resumes dividends

Dis-Chem CFO Rui Morais talks to Business Day TV about their latest financial results

Next week is key as Netcare braces for third wave in Gauteng

Hospital group returns to profit in its first half, but the recovery falls short of pre-pandemic performance

WATCH: How phase 2 of the vaccine rollout is now under way

Discovery Health CEO Ryan Noach talks to Business Day TV about SA’s vaccination drive

WATCH: Is waiving vaccine patents the panacea?

Michael Avery and a panel of experts talk about the US backing India and SA’s bid to temporarily lift patent protection for Covid-19 vaccines

WATCH: Why Ascendis has agreed to a debt-for-asset swap

Ascendis Health CEO Mark Sardi talks to Business Day TV about swapping its European assets for debt

Ascendis looks set to be solely a local player after agreeing to debt-for-asset swap

The debt-laden group’s shares rose more than 14% after it said it had struck a deal with lenders to swap many of its best assets for debt

Ascendis shares volatile ahead of possible restructuring deal

The group’s shares are on track for their worst day in two months after rocketing 42% ahead of a deadline for restructuring talks

Germany’s BioNTech raises vaccine sales outlook to €12.4bn

Vaccine producer hikes sales forecast, up from nearly €10bn, as orders roll in

PODCAST | The future of healthcare in a digital world

Mudiwa Gavaza is joined by Ryan Noach, the CEO of Discovery Health

Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.